September was full
of events for the pharma and biotech community.
GCT President, Dr.
Jeffrey Apter, participated at the annual Autumn conference organized by the
International Society for CNS Clinical Trials and Methology (ISCTM).
From 21 to 25 of
September professionals all over the world took part virtually in the #ISCTM2020.
The topics addressing clinical,
regulatory, methodological and policy challenges in CNS clinical trials were among
the many discussed.
GCT is a global
CRO focused on CNS and Neurology clinical trials, and on the market since 2001.
Dr. Jeffrey Apter, GCT president is the Key Opinion Leader in psychiatry specializing
in Alzheimer’s disease and Depression research. Should you have any questions
or require information about clinical trials, please contact us at bd@gctrials.com